Literature DB >> 15337252

Selective reduction of chromogranin A-like immunoreactivities in the prefrontal cortex of schizophrenic subjects: a postmortem study.

Takeshi Iwazaki1, Isao Shibata, Shin-Ichi Niwa, Izuru Matsumoto.   

Abstract

It is suggested that secretogranins/chromogranins play a role in regulating secretion of various proteins and amines, including neurotransmitters from secretory granules. Several studies have implicated the importance of altered synaptic connectivity in schizophrenia. We employed immunohistochemical techniques to determine if the level of chromogranin A (CgA)-immunoreactivity (IR) was altered in the subjects with schizophrenia. Nine subjects with schizophrenia and nine age- and sex-matched control subjects were selected for this study. Immunohistochemistry using specific antibody against CgA was performed on sections of prefrontal cortex and hippocampus. Images of CgA-IR were analyzed by computer-based image analyzing software. CgA-IR was significantly decreased in layers III-V of the prefrontal cortex in schizophrenic subjects compared with control subjects. In the hippocampus, no significant difference was observed between two groups. The results indicate that there may be a decrease in the number of CgA positive large dense-core vesicles per terminal, and/or in the number of CgA positive terminals, suggesting possible functional impairment of prefrontal synaptic contact in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337252     DOI: 10.1016/j.neulet.2004.06.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder.

Authors:  Joel Jakobsson; Mats Stridsberg; Henrik Zetterberg; Kaj Blennow; Carl-Johan Ekman; Anette G M Johansson; Carl Sellgren; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

Review 2.  Chromogranin peptides in brain diseases.

Authors:  Michael Willis; Irmgard Leitner; Kurt A Jellinger; Josef Marksteiner
Journal:  J Neural Transm (Vienna)       Date:  2011-04-30       Impact factor: 3.575

3.  Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.

Authors:  Yasuto Kunii; Keiko Ikemoto; Akira Wada; Qiaohui Yang; Takashi Kusakabe; Toshimitsu Suzuki; Shin-Ichi Niwa
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

4.  Inositol 1,4,5 trisphosphate receptor and chromogranin B are concentrated in different regions of the hippocampus.

Authors:  Nils H Nicolay; Daniel Hertle; Wolfgang Boehmerle; Felix M Heidrich; Mark Yeckel; Barbara E Ehrlich
Journal:  J Neurosci Res       Date:  2007-07       Impact factor: 4.164

5.  Maternal-fetal unit interactions and eutherian neocortical development and evolution.

Authors:  Juan F Montiel; Heidy Kaune; Manuel Maliqueo
Journal:  Front Neuroanat       Date:  2013-07-19       Impact factor: 3.856

6.  Associations between SNPs and immune-related circulating proteins in schizophrenia.

Authors:  Man K Chan; Jason D Cooper; Stefanie Heilmann-Heimbach; Josef Frank; Stephanie H Witt; Markus M Nöthen; Johann Steiner; Marcella Rietschel; Sabine Bahn
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

7.  Cell type-specific DNA methylation analysis of the prefrontal cortex of patients with schizophrenia.

Authors:  Junko Ueda; Miki Bundo; Yutaka Nakachi; Kiyoto Kasai; Tadafumi Kato; Kazuya Iwamoto
Journal:  Psychiatry Clin Neurosci       Date:  2021-07-22       Impact factor: 5.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.